G. Lebek

482 total citations
50 papers, 364 citations indexed

About

G. Lebek is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, G. Lebek has authored 50 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in G. Lebek's work include Antibiotic Resistance in Bacteria (13 papers), Mycobacterium research and diagnosis (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). G. Lebek is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Mycobacterium research and diagnosis (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). G. Lebek collaborates with scholars based in Switzerland, Germany and Slovakia. G. Lebek's co-authors include Andreas Gerber, Richard Egger, W. Knapp, V. Krčméry, Jana Navarová, H Knothe, Mary Ellen Kitler, U. B. Schaad, Martin Luginbühl and Richard Kraemer and has published in prestigious journals such as The Journal of Infectious Diseases, Infection and Immunity and Cellular and Molecular Life Sciences.

In The Last Decade

G. Lebek

41 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Lebek Switzerland 10 144 103 87 72 52 50 364
Gisela Korfmann Germany 10 259 1.8× 143 1.4× 145 1.7× 53 0.7× 29 0.6× 12 384
N. Harnett Canada 10 72 0.5× 71 0.7× 83 1.0× 32 0.4× 71 1.4× 23 328
Joachim Meyer Germany 4 387 2.7× 119 1.2× 65 0.7× 90 1.3× 30 0.6× 6 436
Kiyomi Okamoto Japan 7 291 2.0× 166 1.6× 84 1.0× 112 1.6× 42 0.8× 8 381
M. Michéa-Hamzehpour Switzerland 10 335 2.3× 214 2.1× 81 0.9× 216 3.0× 74 1.4× 18 554
Victoria M. Hughes United Kingdom 8 319 2.2× 165 1.6× 130 1.5× 47 0.7× 40 0.8× 10 588
G. Vedel France 11 216 1.5× 101 1.0× 25 0.3× 71 1.0× 104 2.0× 23 350
M. C. Negri Spain 7 214 1.5× 52 0.5× 43 0.5× 120 1.7× 33 0.6× 9 326
Kumiko Kawamura‐Sato Japan 9 173 1.2× 161 1.6× 53 0.6× 26 0.4× 51 1.0× 10 381
Claudia Cramer Germany 9 105 0.7× 142 1.4× 56 0.6× 42 0.6× 32 0.6× 13 384

Countries citing papers authored by G. Lebek

Since Specialization
Citations

This map shows the geographic impact of G. Lebek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Lebek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Lebek more than expected).

Fields of papers citing papers by G. Lebek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Lebek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Lebek. The network helps show where G. Lebek may publish in the future.

Co-authorship network of co-authors of G. Lebek

This figure shows the co-authorship network connecting the top 25 collaborators of G. Lebek. A scholar is included among the top collaborators of G. Lebek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Lebek. G. Lebek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebek, G. & H. Cottier. (2015). Notes on the Bacterial Content of the Gut. Current studies in hematology and blood transfusion. 1–18.
2.
Lebek, G.. (2010). Einflüsse der antibakteriellen Arzneimittel im Tierfutter auf das Auftreten von antibiotika- und chemoresistenten, pathogenen Bakterien. Zentralblatt für Veterinärmedizin Reihe B. 17(1). 103–115. 2 indexed citations
3.
Lebek, G., et al.. (1993). A Method for Typing Listeria monocytogenes Strains by Classification of Listeriocins and Phage Receptors. Zentralblatt für Bakteriologie. 278(1). 58–68. 9 indexed citations
4.
Kitler, Mary Ellen, et al.. (1992). Lactitol and Lactulose. Clinical Drug Investigation. 4(1). 73–82. 9 indexed citations
5.
Lebek, G., et al.. (1988). Haemolytic activity and characteristics of plasmid and chromosomally borne hly genes isolated from E. coli of different origin. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 267(4). 485–494. 5 indexed citations
6.
Lebek, G., et al.. (1987). The chromosomal fur gene regulates the extracellular haemolytic activiy encoded by certain hly plasmids. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 266(1-2). 231–238. 10 indexed citations
7.
Lebek, G., et al.. (1987). An approach of the in vivo antibacterial activity of benzoxonium chloride and comparison with other buccopharyngeal disinfectants.. PubMed. 37(4). 467–71. 2 indexed citations
8.
Lebek, G., et al.. (1985). Relation between the hemolytic property and iron metabolism in Escherichia coli. Infection and Immunity. 50(3). 682–686. 36 indexed citations
9.
Navarová, Jana, et al.. (1981). Occurrence of aminoglycoside-modifying enzymes in resistant strains of enterobacteria and Pseudomonas aeruginosa from several countries. Journal of Antimicrobial Chemotherapy. 8(3). 175–185. 11 indexed citations
10.
Lebek, G.. (1979). Nutritive antibiotic additives in animal feeding stuffs-a further form of environmental pollution.. 168. 562–567. 2 indexed citations
11.
Lebek, G., et al.. (1979). [6 years of legally ordered abstinence from therapeutically utilized antibiotics as nutritional feed supplements in Switzerland antibiotics as nutritional feed supplements in Switzerland--random sampling of animal feces in various agricultural institutions].. PubMed. 121(6). 295–309. 1 indexed citations
12.
Lebek, G., et al.. (1973). [Protein binding of gentamicin].. PubMed. 62(14). 441–3. 1 indexed citations
13.
Lebek, G.. (1972). [Extra-chromosomal, transmissible antibiotic resistance in human pathogens].. PubMed. 43(1). 45–60. 1 indexed citations
14.
Lebek, G.. (1969). Die infektiöse, bakterielle Antibiotikaresistenz. 7 indexed citations
15.
Lebek, G., et al.. (1964). Infektiöse Mehrfachresistenz gegen Antibiotika und Sulfonamide bei Ruhrbakterien1. DMW - Deutsche Medizinische Wochenschrift. 89(52). 2464–2467. 3 indexed citations
17.
Lebek, G.. (1963). [THE TRANSMISSION OF MULTIPLE RESISTANCE TO ANTIBIOTICS AND CHEMOTHERAPEUTIC AGENTS IN THEIR SIGNIFICANCE FOR HOSPITALISM WITH MULTIPLE RESISTANT GRAM-NEGATIVE INTESTINAL BACTERIA].. PubMed. 191. 387–95.
18.
Lebek, G.. (1959). [Dependence of the oxygen optimal concentration of both strains of mammalian Mycobacterium tuberculosis on the nutritive substrate].. PubMed. 176. 530–7. 2 indexed citations
19.
Lebek, G.. (1958). [Determination of different optimal oxygen concentrations in the human & bovine Mycobacterium tuberculosis; contribution to the type determination of tubercle bacilli with mammalian pathogenicity].. PubMed. 173(7-8). 581–7. 4 indexed citations
20.
Lebek, G.. (1958). [The presence of pigment-forming Mycobacteria in humans suspected of tuberculosis].. PubMed. 12(1). 39–41. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026